MANILA, Philippines — Recipients of the vaccine under the World Health Organization (WHO) Solidarity Trials will come from the top five to 10 barangays in the country with the highest COVID-19 cases, the Inter-Agency Task Force (IATF) on Emerging Infectious Diseases said.
According to IATF’s Resolution No. 68, it will be based on the “attack rates per 1000 population per barangay,” the data of which coming from the Department of Health’s (DOH) Epidemiology Bureau.
“Trial sites will be at the barangay level, and randomization will be by households. The household census will be obtained from the barangay/s to identify residents to ensure follow up,” the resolution dated Sept. 3 and released to the press on Monday said.
The DOH will be responsible for monitoring and managing the database of all trial participants.
The Philippines is just among some 45 countries that will contribute to WHO’s search for the treatment of the novel coronavirus, which has sickened over 27 million people worldwide.
The Department of Science and Technology earlier said clinical trials in the Philippines for various COVID-19 vaccines will most likely start by the fourth quarter of 2020.